PUK15 a Managed Care Cost-Offset Model for Ferric Citrate, an Experimental Phosphate Binder That Can Reduce the Use of Erythropoiesis-Stimulating Agents and Intravenous Iron in Hemodialysis Patients with Hyperphosphatemia

✍ Scribed by R. Mutell; J.L. Rubin; T.C. Bond; T. Mayne

• Book ID: 119311762
• Publisher: John Wiley and Sons
• Year: 2012
• Tongue: English
• Weight: 60 KB
• Volume: 15
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/j.jval.2012.03.835